March 2023 Foundation eNews

Ashley RosenbrockFoundation eNews, Home Page

Foundation News  Tune in tomorrow: FDA meeting on tofersen The U.S. Food and Drug Administration (FDA) will hold an advisory committee meeting on Wednesday, March 22 to review Biogen’s New Drug Application for accelerated approval of tofersen, a treatment for …

March 2023 Foundation eNews

Ashley RosenbrockFoundation eNews, Home Page

Foundation News FDA Advisory Committee meeting on tofersen, an SOD1-ALS treatment set for March 22  The U.S. Food and Drug Administration (FDA) will hold an advisory committee meeting on March 22 to review Biogen’s New Drug Application (NDA) for accelerated …

February 2023 Foundation eNews

Ashley RosenbrockFoundation eNews, Home Page

Foundation News Calming the destructive cells of ALS One of the reasons that ALS can progress quickly is that certain types of cells in the human body will attack diseased upper motor neurons, which are needed to initiate movement. Once …